Friday, March 28, 2014
Wisconsin Updated Pharmacy and Compounding Laws
CHAPTER 450 - Wisconsin Legislative Documents
https://docs.legis.wisconsin.gov/document/.../450.p...
Wisconsin Legislature
Loading...
USP Expert Committee Meeting Agenda for April 3, 2014 Includes discussion of compounding policy topics
Expert Committee
Meeting #08
Thursday, April 3, 2014
Meeting #8
USP Headquarters, Rockville, Maryland
Briggs Parker Room; Marshall Room; Wiley Room; Wood Room
Preliminary Agenda
_____________________
Goals and Anticipated Outcomes
1. Discuss compounding policy topics
2. Discuss subcommittee reports
Attendees
| Attendee list provided on the day of the meeting Thursday, April 3, 2014 | |||
| 7:30 a.m. | Chair / Vice Chair Meeting | ||
| 8:00 a.m. | CONTINENTAL BREAKFAST | All | |
| 8:30 a.m. |
1. Welcome |
||
|
a. Welcome, Call Meeting to Order |
Ms. Davidson | ||
|
b. Procedural Announcements |
Mr. Knaack/Ms. Meyer | ||
|
c. Introduction of new CEO Ron Piervincenzi, Ph.D. |
Ms. Long | ||
|
d. Approval of Minutes |
Ms. Davidson | ||
|
e. Approval of the Agenda |
Ms. Davidson | ||
|
f. Chair Overview of Expert Committee Progress |
Ms. Davidson | ||
| 9:00 a.m. |
2. Progress Updates/Subcommittee Reports |
||
|
a. General Chapter <797> |
Ms. Davidson | ||
|
b. General Chapter <795> and <1163> |
Ms. Ashworth | ||
| 2:00 p.m. |
4. Compendial Updates |
|
a. COE Call for Candidates |
Mr. Sindaco |
|
b. Proposed General Chapter <909> Uniformity of Dose From Oral Suspensions In Multiple-Unit Containers |
Mr. Brown |
|
c. Safety and Labeling Updates |
Ms. Bohannon |
|
d. Organic Impurities in Drug Substances and Drug Products |
Dr. Parr/ Mr. Hernandez-Cardoso |
|
e. Good Distribution Practices |
Dr. Hunt |
Be Sure and Checkout PCCA's Compounding Success Stories--Showing There Are Good Compounding Pharmacies and Pharmacists and Why We Need and Must Have Good Compounding Pharmacists
PCCA's Compounding Success Stories can be found here
Maryland Senate holds hearing on Compounding Legislation
Health Occupations - Compound Drugs - Provision to Ophthalmologists for Office Use | |||
Sponsored by: | Delegate Morhaim | ||
Status: | In the Senate - Hearing 3/27 at 1:00 p.m. |
| Synopsis: | Authorizing a pharmacy for which a pharmacy permit has been issued by the State Board of Pharmacy and a sterile compounding facility to provide to an ophthalmologist for office use, without a patient-specific prescription, specified compound drugs for specified purposes; requiring the pharmacy or sterile compounding facility to require the ophthalmologist to provide to the pharmacy or sterile compounding facility the identity of any patient to whom the drugs are administered; etc. | ||
|---|---|---|---|
| Analysis: | Fiscal and Policy Note (Revised) | ||
| All Sponsors: | Delegates Morhaim, Bromwell, Costa, Cullison, Donoghue, Elliott, Hammen, Hubbard, Kach, A. Kelly, Kipke, Krebs, McDonough, Murphy, Nathan-Pulliam, Pena-Melnyk, Pendergrass, Ready, Reznik, Tarrant, and V. Turner | ||
| Additional Facts: | Bill File Type: Regular Effective Date(s): July 1, 2014 | ||
| Committee(s): |
| ||
| Broad Subject(s): | Health Occupations | ||
| Narrow Subject(s): | Committees and Commissions -see also- Political Committees Drugs -see also- Controlled Dangerous Sub; Substance Abuse Emergency Medical Services Federal Government Ophthalmologists Pharmacists and Pharmacies Reports Storage | ||
| Statutes: | Article - Health Occupations(12-403, 12-4A-12) |
Letter: Consumers must be able to make decisions on meds
To the editor of THE EAGLE: I visit the Berkshires often and will retire here in a few years. Born and raised in Connecticut, I love this part of the country. It’s home. For a few more years, though, we must live in New Jersey, as that’s where my husband works. Our doctors are in New Jersey. When I need a prescription there, I can tell my pharmacist when I want a brand name drug. I don’t need permission from anyone to do this. I just need to pay more money, as the cost of the brand is more than the generic and insurance doesn’t usually cover the brand.
continue to read here
continue to read here
TDCJ Will Appeal Judge's Ruling on Execution Drugs
Amid national debate over the disclosure of information about drugs used in executions, Texas Department of Criminal Justice officials said Thursday that they will appeal a judge’s order to disclose the supplier of a new batch of its execution drugs.
“We are disappointed in the district court's decision and will be appealing the ruling to a higher court,” TDCJ spokesman Jason Clark said in an email.
continue to read here
“We are disappointed in the district court's decision and will be appealing the ruling to a higher court,” TDCJ spokesman Jason Clark said in an email.
continue to read here
Imprimis Announces Compounding Pharmacy Strategy
Compounding Pharmacy Strategy
One of our key strategies is the use of compounding pharmacies to formulate our proprietary compounded drug formulations and technologies and distribute them to physicians and patients. Governed by state and federal statutes and regulations, including the Drug Quality and Security Act of 2013 (DQSA), compounding pharmacies work with physicians to develop medications for individually identified patients. Examples of compounded formulations include medications with alternative dosage strengths or unique dosage forms, such as topical creams or gels, suspensions or solutions with more tolerable drug delivery vehicles. A physician may also work together with a pharmacist to repurpose or reformulate FDA-approved drugs via the compounding process to meet a patient’s specific medical needs. We are strategically attentive to the ideas generated by pharmacists dealing directly with doctors and their patients to address specific and often unmet patient needs, and we believe in and support the important role and contribution of the compounding pharmacist and compounding pharmacies in the U.S. healthcare system.
quoted from here
quoted from here
Subscribe to:
Posts (Atom)